chr2-47414420-TAAAAAAAAA-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The ENST00000233146.7(MSH2):​c.942+3_942+11delAAAAAAAAA variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000686 in 1,043,724 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). The gene MSH2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0018 ( 2 hom., cov: 0)
Exomes 𝑓: 0.00061 ( 0 hom. )

Consequence

MSH2
ENST00000233146.7 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.75

Publications

4 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Genomics England PanelApp
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000233146.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 2-47414420-TAAAAAAAAA-T is Benign according to our data. Variant chr2-47414420-TAAAAAAAAA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1692300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00182 (113/62244) while in subpopulation AFR AF = 0.00511 (99/19380). AF 95% confidence interval is 0.00429. There are 2 homozygotes in GnomAd4. There are 54 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000233146.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.942+21_942+29delAAAAAAAAA
intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.942+21_942+29delAAAAAAAAA
intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.942+21_942+29delAAAAAAAAA
intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.942+3_942+11delAAAAAAAAA
splice_region intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.942+3_942+11delAAAAAAAAA
splice_region intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.993+3_993+11delAAAAAAAAA
splice_region intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.00182
AC:
113
AN:
62242
Hom.:
2
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00511
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00290
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000903
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000311
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000614
AC:
603
AN:
981480
Hom.:
0
AF XY:
0.000613
AC XY:
299
AN XY:
487784
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00232
AC:
50
AN:
21572
American (AMR)
AF:
0.00268
AC:
50
AN:
18652
Ashkenazi Jewish (ASJ)
AF:
0.00108
AC:
16
AN:
14754
East Asian (EAS)
AF:
0.000932
AC:
22
AN:
23616
South Asian (SAS)
AF:
0.000296
AC:
17
AN:
57420
European-Finnish (FIN)
AF:
0.00182
AC:
39
AN:
21424
Middle Eastern (MID)
AF:
0.000399
AC:
1
AN:
2506
European-Non Finnish (NFE)
AF:
0.000470
AC:
368
AN:
783022
Other (OTH)
AF:
0.00104
AC:
40
AN:
38514
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.292
Heterozygous variant carriers
0
51
103
154
206
257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00182
AC:
113
AN:
62244
Hom.:
2
Cov.:
0
AF XY:
0.00196
AC XY:
54
AN XY:
27578
show subpopulations
African (AFR)
AF:
0.00511
AC:
99
AN:
19380
American (AMR)
AF:
0.00290
AC:
12
AN:
4140
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1768
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1634
South Asian (SAS)
AF:
0.000906
AC:
1
AN:
1104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
100
European-Non Finnish (NFE)
AF:
0.0000311
AC:
1
AN:
32194
Other (OTH)
AF:
0.00
AC:
0
AN:
780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.570
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.7
Mutation Taster
=70/30
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11309117;
hg19: chr2-47641559;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.